Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    1658941 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
Conditions: Osteoporosis;   Humoral Hypercalcemia of Malignancy;   Hyperparathyroidism
Intervention: Drug: PTHrP (1-36)
2 Completed
Has Results
7 Day Continuous Parathyroid Hormone IV Infusion
Conditions: Osteoporosis;   Bone Diseases, Endocrine;   Hyperparathyroidism
Intervention: Drug: Parathyroid Hormone (1-34)

Study has passed its completion date and status has not been verified in more than two years.